KLAS Validates BytePad: 100% of Customers Would Buy Again.
In February 2026, KLAS Research published its Emerging Company Spotlight on InterScripts BytePad. Across all 4 interviewed customer organizations, BytePad achieved 100% Would-Buy-Again, 100% Keeps-All-Promises, an A+ Likely-to-Recommend rating, and A+ scores for Executive Involvement, Ease of Use, and Money’s Worth. Zero respondents were dissatisfied.
Lead Author: Benjamin Cassity · Co-Author: Drew Partridge · Methodology: 5 individuals from 4 organizations (100% of eligible live customers). Customer-validated EHR integration: Epic.
The numbers that matter most.
Four KLAS metrics where 100% of interviewed customers answered yes. The full A/A+/A- grade matrix and methodology are in the downloadable report below.
100%
Would Buy Again
n=4
100%
Keeps All Promises
n=4
100%
Avoids Charging for Every Little Thing
n=4
100%
Part of Long-Term Plans
n=4
Adoption of key BytePad functionality
Percentage of interviewed organizations actively using each capability (n=3).
AI-enabled search capability
100%
Easy-to-install technology & minimal end-user training
100%
Proprietary delivery program
100%
Seamless data embedding (BI dashboards)
100%
Integrated patient chart framework
67%
What KLAS-interviewed customers said
Direct quotes from healthcare executives interviewed by KLAS for the February 2026 report.
“BytePad from InterScripts centralizes archiving and access for legacy data across multiple hospitals and systems, including EMRs and specialty systems. The platform allows legacy data to be easily operationally accessed, supports smooth decommissioning of old applications, and incorporates AI tools for advanced search and data extraction.”
“InterScripts is very fair. They want their customers to be successful, and they will go above and beyond to make their customers successful. InterScripts is very customer focused. When we have needed additional resources, InterScripts’ people have been readily available.”
“InterScripts has saved us a considerable amount of money. They want to see us succeed... that is so far beyond any partnership with a vendor I have had before. They were willing to work with us on costs when needed.”
“We chose BytePad over other solutions due to its cost and the pricing model that the vendor offered. BytePad has a fixed price instead of a variable price, and it is more cost effective.”
“One of the biggest positives is that there is virtually no training needed to use BytePad. BytePad is inherently easy to use. We have heard the comments that BytePad is better than any of the EMRs we have had with patients. Everything is right there in one spot to do whatever we need.”
“InterScripts is very responsive to customers. The vendor is easy to work with. They are customer oriented. They remind me a lot of how Epic was back in the day. They are very focused on working with our needs and getting our solutions in place.”
Three strengths validated by KLAS
Customer-focused partnership
Exceptional service, investment in customer success, and flexibility — the trait every interviewed customer cited first.
Exceptional value and cost-effectiveness
Fixed-price model and willingness to work with customers on cost; enables organizations to actually execute archival projects that were previously deferred for budget reasons.
Easy-to-use, intuitive technology
Minimal training required, browser-based delivery, AI Global Search across the entire archived corpus — reduces operational burden for clinicians and HIM teams.
How BytePad achieved 100% outcome delivery
KLAS surveyed customers on four expected outcomes. All four were rated achieved. Here's the capability behind each.
Cost savings from decommissioning legacy systems
Application rationalization workflow + fixed-price licensing model retire entire EMR/specialty footprints in 90-120 days, replacing six-figure annual maintenance contracts with a single archive license.
Single source for legacy data
Integrated patient chart framework aggregates and harmonizes data from disparate legacy clinical systems into one unified view, removing the need for clinicians to log into retired systems.
Improved compliance (HIPAA, PHI, audit readiness)
HITRUST r2, SOC 2 Type 2, ISO 27001/27018/22301/9001 controls; AES-256 at rest, TLS 1.2 in transit; full audit trail of every record access for HIPAA and PHI evidence.
Ease of use & minimal training required
Intuitive role-based design and prebuilt modules; AI Global Search enables natural-language retrieval of patient context across the entire archived corpus — no SQL, no specialist training.
KLAS-identified opportunities & our response
The KLAS report is balanced — it surfaces two areas for improvement. Here's how we're addressing both publicly.
KLAS finding 1
“Reduce sales emphasis and continue to try to exceed expectations with current service lines.”
InterScripts response
Acknowledged. InterScripts is instituting Quarterly Business Reviews with every BytePad customer to align on outcomes, surface needs proactively, and replace product-line solicitation with customer-led discovery.
KLAS finding 2
“Enhance unique product innovation and share road map while continuing to meet evolving needs.”
InterScripts response
Acknowledged. The 2026–2027 BytePad public roadmap (AI Global Search expansion, FHIR R5 readiness, additional EHR source coverage, local-GPT deployments) will be published Q3 2026, with quarterly innovation updates thereafter.
Read the full KLAS report
The full 5-page KLAS Emerging Company Spotlight: InterScripts BytePad 2026 covers detailed methodology, the full grade distribution, every customer comment, and the InterScripts company profile. Lead author Benjamin Cassity, co-author Drew Partridge.
Shared with permission from KLAS Research · 5 pages · 662 KB
About KLAS Research
KLAS Research is the independent, healthcare-focused analyst firm that has measured vendor performance through verified customer interviews since 1996. Their Best in KLAS awards, Emerging Company Spotlights, and category reports are the most-cited customer-validation source across U.S. health systems, IDNs, and federal healthcare buyers.
Reports are published from KLAS headquarters at 365 S. Garden Grove Lane, Suite 300, Pleasant Grove, UT 84062. Learn more about KLAS methodology →
Methodology note: The KLAS Emerging Company Spotlight on InterScripts BytePad 2026 reflects responses from 5 individuals representing 4 customer organizations, comprising 100% of customers eligible for inclusion at time of publication. Per KLAS methodology, sample sizes of 3–5 are considered emerging data; scores may evolve significantly as the customer base grows. Customer-validated EHR integration: Epic. Report © 2026 KLAS Enterprises, LLC. All Rights Reserved. Direct quotes reproduced for the limited purpose of informing prospective customers about independent third-party validation of InterScripts BytePad.